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Introduction
Electrical and contractile dysfunction of the atria are frequent 
components of cardiac disease development, often culminating in 
atrial fibrillation (AF), a leading cause of ischemic stroke, which 
is predicted to triple in prevalence by 2050 (1). Among the risk 
factors associated with atrial dysfunction, hypertension is present 
in 60% to 80% of European patients (2). Using rapid pacing, key 
aspects of atrial remodeling and AF were reproduced in large ani-
mal models: whereas electrical and ionic changes occurred within 
minutes, intracellular Ca2+ overload was normal by 48 hours (3). 
Recently, high atrial pacing rates were shown to induce Ca2+-sig-
naling silencing, preventing intracellular Ca2+ overload, albeit at 
the cost of depressed contractile function (4). Hypertrophy with 
depressed contractile function occurred as early as 2 days after 
pacing, in the absence of fibrosis or dilation in canine atria (5). 
These studies support the therapeutically relevant notion that 
electrical and metabolic disease mechanisms may cause contrac-
tile atrial dysfunction relatively early, preceding AF.
Atrial myocytes (AM) are distinguished from ventricular myo-
cytes (VM) by their smaller diameter, which may explain why no or 
few transverse tubules (TT) could support adequate AM function 
(6–8). In contrast, VMs are characterized by high TT density and 
regularity in normal hearts, a feature lost in heart failure (HF) (9, 
10). Given the regular presence of TTs at sarcomeric Z-lines, TT 
density is thought to determine uniform Ca2+ release in VMs (11). 
Paradoxically, despite sparse irregular TT components, contrac-
tile activation of atrial muscle from small and large animal species 
occurs faster than in ventricular tissue (12). Hence, there is a gap 
in understanding the mechanisms that underlie rapid activation of 
atrial contraction. In addition, even though atrial dysfunction and 
arrhythmias are recognized as a leading cause of cardiac disease 
burden, fundamental details about the subcellular mechanisms 
involved remain unclear (13).
In the absence of abundant TT membrane invaginations, 
AMs are thought to initiate excitation-contraction coupling (ECC) 
through Ca2+ release units (CRUs) at the surface sarcolemma, each 
including approximately 6 L-type Ca2+ channels (LCCs/Cav1.2) 
opposite a cluster of approximately 50 RyR2 Ca2+ release channels, 
separated by a subspace of approximately 15 nm width (14, 15). In 
this model, Ca2+ transients are activated through subsarcolemmal 
CRUs, leading initially to peripheral elevation of Ca2+, which trav-
els toward the AM center through propagated Ca2+-induced Ca2+ 
The canonical atrial myocyte (AM) is characterized by sparse transverse tubule (TT) invaginations and slow intracellular 
Ca2+ propagation but exhibits rapid contractile activation that is susceptible to loss of function during hypertrophic 
remodeling. Here, we have identified a membrane structure and Ca2+-signaling complex that may enhance the speed of atrial 
contraction independently of phospholamban regulation. This axial couplon was observed in human and mouse atria and 
is composed of voluminous axial tubules (ATs) with extensive junctions to the sarcoplasmic reticulum (SR) that include 
ryanodine receptor 2 (RyR2) clusters. In mouse AM, AT structures triggered Ca2+ release from the SR approximately 2 times 
faster at the AM center than at the surface. Rapid Ca2+ release correlated with colocalization of highly phosphorylated 
RyR2 clusters at AT-SR junctions and earlier, more rapid shortening of central sarcomeres. In contrast, mice expressing 
phosphorylation-incompetent RyR2 displayed depressed AM sarcomere shortening and reduced in vivo atrial contractile 
function. Moreover, left atrial hypertrophy led to AT proliferation, with a marked increase in the highly phosphorylated 
RyR2-pS2808 cluster fraction, thereby maintaining cytosolic Ca2+ signaling despite decreases in RyR2 cluster density and 
RyR2 protein expression. AT couplon “super-hubs” thus underlie faster excitation-contraction coupling in health as well 
as hypertrophic compensatory adaptation and represent a structural and metabolic mechanism that may contribute to 
contractile dysfunction and arrhythmias.
Axial tubule junctions control rapid calcium signaling 
in atria
Sören Brandenburg,1,2 Tobias Kohl,1,2 George S.B. Williams,3 Konstantin Gusev,1,2 Eva Wagner,1,2,4 Eva A. Rog-Zielinska,5  
Elke Hebisch,6 Miroslav Dura,1,2 Michael Didié,1,2 Michael Gotthardt,7,4 Viacheslav O. Nikolaev,1,2,4 Gerd Hasenfuss,1,2,4  
Peter Kohl,5,8 Christopher W. Ward,3 W. Jonathan Lederer,3 and Stephan E. Lehnart1,2,4
1Heart Research Center Göttingen and 2Clinic of Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany. 3BioMET, Center for Biomedical Engineering and Technology,  
University of Maryland School of Medicine, Baltimore, Maryland, USA. 4German Centre for Cardiovascular Research (DZHK) site Göttingen, Germany. 5Imperial College London, National Heart and Lung 
Institute, London, United Kingdom. 6 Department of NanoBiophotonics, Max-Planck Institute for Biophysical Chemistry, Göttingen, Germany. 7Max Delbrück Center for Molecular Medicine, Berlin, Germany.  
8University Heart Centre, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
     Related Commentary: doi:10.1172/JCI90348
Conflict of interest: The authors declare that no conflict of interest exists.
Submitted: April 27, 2016; Accepted: August 9, 2016.
Reference information: J Clin Invest. doi:10.1172/JCI88241.
Downloaded from http://www.jci.org on October  3, 2016.   http://dx.doi.org/10.1172/JCI88241
The Journal of Clinical Investigation R E S E A R C H  A R T I C L E
2 jci.org
Downloaded from http://www.jci.org on October  3, 2016.   http://dx.doi.org/10.1172/JCI88241
The Journal of Clinical Investigation   R E S E A R C H  A R T I C L E
3jci.org
tinguishable from minimally phosphorylated nonjunctional RyR2 
clusters. This correlated with substantially earlier Ca2+ release 
from AT-associated RyR2 clusters and faster central sarcomere 
shortening, leading to a new model of atrial contractile regulation.
Results
AMs contain cell-wide TAT membrane networks. Although earlier 
electron microscopy–based (EM-based) representations of AMs 
(6), recent confocal data, and computational models (19) suggest 
that there are few, if any, TT invaginations, experimental studies 
have increasingly highlighted the presence of atrial TAT networks 
in several mammalian species, including humans (20–22). To 
clarify this apparent contradiction, we used membrane-preserv-
ing workflows developed for high-resolution live-cell imaging (9, 
18) that revealed abundant TAT membrane structures in murine 
AMs (Figure 1A and Supplemental Figure 1A; supplemental mate-
rial available online with this article; doi:10.1172/JCI88241DS1). 
We identified intact TAT networks in 100% of the AMs examined 
(n = 29), thus confirming the presence of preserved membrane 
structures. Using skeletonized images, we visualized individu-
al TAT components and analyzed their orientations (Figure 1A, 
magenta). In confocal sections, the cell-wide TAT network density 
in AMs was lower (by ~24%) than in VMs (isolated from the same 
hearts), attributable chiefly to a significantly lower presence of TT 
components (Figure 1B), which dominate TAT networks in VMs 
(Supplemental Figure 1B). Despite smaller dimensions (Supple-
mental Figure 2) and a low TT abundance, mouse AMs contained 
significantly more ATs than VMs (Figure 1B). Thus, while cell 
type–specific differences in the abundance of TTs explain a mod-
erately lower TAT network density, AMs showed a significantly 
higher abundance of AT components than did VMs.
Since confocal imaging suggested unusually large AT dimen-
sions (Figure 1C, illustration), we used live-cell stimulated emis-
sion depletion (STED) super-resolution microscopy (nanoscopy) 
to assess the width of intact ATs and TTs (Supplemental Figure 3). 
AT width (293.3 ± 7.7 nm) was significantly greater than TT width 
in AMs (Supplemental Table 1) and approximately 50% larger in 
AMs than in VMs (Figure 1C and Supplemental Table 1). This was 
further investigated using ET and 3D segmentation (23) of semi-
thick sections (280 nm) of high-pressure-frozen AMs (Supple-
mental Figure 4). ET confirmed the presence of voluminous ATs 
containing multiple junctions with the sarcoplasmic reticulum 
(SR) (Figure 1D). The color rendering in Supplemental Figure 4 
highlights extensive AT-SR junctions with a gap width of 15 nm or 
less that contained RyR2 densities (red) covering large regions of 
the AT surface area (Figure 1, D and E). While not perfectly cir-
cular in the cross section, we observed no difference in the mean 
eccentricity of ATs and TTs (0.62 ± 0.05, n = 11 and 0.64 ± 0.04, 
n = 9, respectively; P = 0.7). The measured volume/surface area 
ratio and width were significantly higher for ATs than for TTs in 
AMs (Figure 1F), consistent with the STED measurements. These 
independent techniques confirmed the presence of central-axial 
membrane structures of unusually large size and surface area that 
were distinct from those of VMs, with extensive SR junctions.
AT structures couple excitation to rapid intracellular Ca2+ release. 
TT invaginations, continuous with the surface membrane, contain 
LCCs juxtapositioned with RyR2 clusters in the SR, and similar 
release (CICR) within approximately 100 ms (4, 7). Hence, central 
Ca2+ release should be significantly delayed, consistent with obser-
vations of U-shaped atrial Ca2+ release activation in transversal line 
scans of AMs (4, 16, 17). Such slow atrial ECC is at odds, though, 
with the rapid mechanical activation dynamics of atrial muscle 
(12). We hypothesize that AM-specific components of the trans-
verse axial tubule (TAT) system combine molecular functions with 
rapid Ca2+ signal activation in a highly localized manner in AMs.
Our investigations were made possible by recent methodolog-
ical advances, which provide high-quality samples for imaging of 
intact AM membrane structures (9, 18). While intracellular TAT 
structures are generally robust and functional throughout AMs, as 
described below, it was remarkable to observe large axial tubule 
(AT) structures connected through a sparse pattern of TTs. The 
unusually voluminous ATs are functionally coupled to RyR2 clus-
ters in axial couplons, which form extensive junctional complex-
es that allow the rapid central Ca2+ signaling that we investigated 
by high-resolution live-cell imaging, electron tomography (ET), 
patch-clamp recordings, and mathematical modeling. Unexpect-
edly, RyR2 clusters colocalized with AT membranes were highly 
phosphorylated in situ by protein kinase A (PKA) and Ca2+-calm-
odulin–dependent protein kinase (CaMK) and hence clearly dis-
Figure 1. Abundant AT structures rapidly activate Ca2+ release. (A) Con-
focal live imaging of di-8-ANEPPS–stained (di8) TAT structures visualized 
as skeletons (pink). N, nucleus. Scale bar: 10 μm. TAT component orien-
tations (histogram) and Gaussian fitting show abundant AT (0°) versus 
sparse TT (90°) components (binning ± 20°). n = 36 AMs. (B) Comparison 
of ventricular versus atrial TAT network length normalized to cell area; 
TT and AT component abundance. n = 36 AMs and 25 VMs. (C) Illustra-
tion conceptualizing AT width (δ) measurements and calculated surface 
area (SA). L, length. AT width was determined from local STED signal 
distributions of optical cross sections (brackets) and is summarized in the 
bar graph. Scale bars: 200 nm. n = 27 VMs, 30 AMs. (D) Double-headed 
arrows indicate potential AT-TT connections; ET images and segmentation 
of longitudinally sectioned and (E) cross-sectioned AT structures. Scale 
bars: 200 nm. Color legend – red, AT-SR junctions ≤ 15nm in gap width and 
containing RyR2 densities; yellow, AT-SR junctions ≤ 20nm in gap width 
but lacking RyR2 densities; green, membrane area with no apparent 
junctions. AT-TT junction; for color rendering, see Supplemental Figure 
4. Arrows indicate exemplary electron densities compatible with RyR2 
channels. (F) Bar graphs comparing TT versus AT volume/surface area 
ratio and width. n = 13 TTs, 23 ATs. Data are representative of 3 hearts. (G 
and H) Confocal images of Cav3-, RyR2-, and Cav1.2-coimmunostained 
mouse and human AMs. Robust Cav3-labeled AT structures in human and 
mouse AMs. Scale bars: 10 μm, magnification ×4. Yellow brackets indicate 
regions magnified. (I) Image segmentation. (J) Box plots summarizing 
TAT-specific Cav1.2 cluster density; component-specific Cav1.2 cluster 
numbers. White boxes indicate the mean; boxes represent the 50th per-
centile and lower and upper SD, and whiskers represent the 10th and 90th 
percentiles. n = 17 AMs. (K) Confocal visualization (negative contrast) of 
AT structures for transversal line scanning (yellow triangles) of intracel-
lular Ca2+ (fluo-4) magnification ×4: field potential–evoked Ca2+ transient 
activated via AT and subsurface (S) structures; black diamonds, off-mem-
brane CY; F25, Ca2+ signal onset at 25% signal amplitude; F/F0, Normal-
ized fluorescence intensity ratio indicated by look-up-table; N, nucleus. 
(L) Relative latency of early Ca2+ signal upstroke (dF/dt) for the indicated 
locations. Data are representative of 19 AMs. (M) Voltage-clamped AMs (1 
mM EGTA) during Ca2+ transient activation. F25, Ca2+ signal onset during 
–75 to 0 mV depolarization. (N) Latency difference of Ca2+ signal upstroke 
(dF/dt). n = 15 AMs. *P < 0.05, **P < 0.01, and ***P < 0.001, by Student’s 
t test (A–F, K–N) and Mann-Whitney U test (J).
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nal onset at AT structures under direct voltage control, we patch 
clamped AMs (1 mM EGTA in the patch; Figure 1M). Analysis of 
Ca2+ signal onset by dF/dt during depolarization to 0 mV con-
firmed the significant AT<S latency (Figure 1N). In summary, elec-
trically evoked Ca2+ transients originate deep inside AMs, from 
AT structures, and do so approximately 2 times earlier than Ca2+ 
transients on the surface membrane. The discovery of more rapid 
central Ca2+ release supports the presence of continuous electrical 
connectivity of ATs with the surface sarcolemma, presumably via 
sparse TTs as a conduit for ECC activation.
Human left atrial myocardium exhibits axial RyR2 cluster mor-
phologies at ATs. To assess whether AT membrane structures are 
associated with junctional RyR2 clusters in human tissue as well, 
we developed dual-color immunolabeling protocols for STED 
nanoscopy of left atrial (LA) tissue sections. Cav3-labeled sections 
showed highly ordered rod-shaped AMs aligned with capillaries in 
atrial tissue (Figure 2A). Interestingly, AMs with robust intracellu-
lar Cav3 staining showed that multiple central ATs regularly inter-
sected with transversal RyR2 cluster striations (Figure 2A), similar 
to our observations in isolated human and mouse AMs (Figure 1G). 
Importantly, higher magnifications inside tissue-embedded AMs 
showed distinct, axially extended RyR2 cluster morphologies, 
which tightly embraced the Cav3-labeled ATs (Figure 2B). Thus, 
central AT–associated (but not off-membrane CY) RyR2 clusters 
revealed a distinct morphology in human LA sections, in keeping 
with the possibility of unique axial couplon functions such as for 
the rapid Ca2+ release onset observed in murine AMs.
Differential regulation of atrial RyR2 clusters. Our finding that 
local Ca2+ release occurs earlier at AT sites suggests potentially 
unknown local regulatory mechanisms. In VMs, TT membranes 
were previously shown to contain β-adrenergic receptor (β-AR) 
and adenylyl cyclase (AC5/6) signaling structures, increasing 
cAMP concentrations locally (26, 27). Furthermore, cAMP sensing 
through PKA is directly tethered to each subunit of the homotetra-
structural features were evident for ATs in our EM AM data (Fig-
ure 1, D and E). To investigate the subcellular relations between 
RyR2 channels and AT structures, we immunolocalized RyR2 
and caveolin 3 (Cav3). While colocalization of Cav3 and RyR2 is 
generally considered to indicate the presence of CRUs at SR con-
tact sites (24), we observed no regular striated distribution due to 
sparse TT elements in AMs (Figure 1G). Instead, robust Cav3-pos-
itive AT structures were abundant in AMs from both mouse and 
human hearts (Figure 1G). Furthermore, Cav1.2 channel clusters 
were frequent and regularly associated with AT structures (Fig-
ures 1, H and I). Analysis of Cav1.2 clusters confirmed a substan-
tial TAT-specific density, and the number of component-specific 
Cav1.2 clusters was significantly higher in AT components than in 
TT components (Figure 1J). Thus, central RyR2 clusters, separated 
by a subsurface gap from the peripheral RyR2 clusters described 
previously (19), colocalize in AMs with abundant AT structures 
that contain a high number of Cav1.2 clusters.
For AT structure-function analysis, we measured Ca2+ tran-
sients in AM using fluo-4 and the membrane-intercalculating 
dye di-8-ANEPPS using protocols established previously (9, 18). 
Transversal line scanning during electrical stimulation revealed 
robust Ca2+ rises, originating from AT sites (Figure 1K). Surpris-
ingly, the spatiotemporal F25 profile (time point at which 25% of 
the maximal fluorescence is reached) indicated earlier Ca2+ tran-
sient onset at ATs than at surface (S) sarcolemmal sites (Figure 
1K). To confirm this, we analyzed Ca2+ signal onset at AT, S, and 
off-membrane cytosolic (CY) locations by assessing the first deriv-
ative of fluorescence intensity (dF/dt) and determined the follow-
ing latency profile: AT<S<<CY (Figure 1L). In contrast, imaging 
planes that excluded visible AT structures showed principally dif-
ferent, U-shaped Ca2+ transient onset patterns (data not shown). 
This result is consistent with the steep S<<CY latency gradients 
we observed (Figure 1L) and agrees with previous observations of 
U-shaped Ca2+ transients (4, 17, 25). To reproduce early Ca2+ sig-
Figure 2. ATs and junctions with RyR2 clusters are common in human 
tissue. Dual-color STED nanoscopy of 2 human LA tissue sections coim-
munostained for Cav3 and RyR2. (A) Tissue section shows AMs aligned 
with capillaries (asterisks indicate the lumens). Magnified images (of red 
boxed area) show 1 Cav3-labeled AT membrane structure (arrowhead), 
which intersects with 6 transversal rows of RyR2 clusters delimited by the 
surface membrane on top. Scale bars: overview 10 μm; magnifications,  
2 μm. (B) Intracellular high-power magnifications showing 2 parallel, axi-
ally aligned RyR2 cluster tracks, perpendicularly intersecting 6 transversal 
RyR2 rows. Arrowheads identify exemplary RyR2 clusters with typical axial 
couplon architectures. RyR2 clusters with elongated axial morphologies 
and Cav3-labeled structures are tightly spaced next to each other, indi-
cating a functional role of AT-associated SR junctions. STED images are 
representative of 5 human LA samples. Scale bar: 2 μm.
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Figure 3. Differential regulation of RyR2 cluster phosphorylation. (A) AMs coimmunostained for RyR2- and PKA-phosphorylated RyR2-pS2808. WT: 
highphos RyR2 clusters (yellow) aligned in central-axial string-of-pearls, intersecting transverse striations of lowphos RyR2 clusters (green); RyR2-
S2808A+/+: zero PKA phosphorylation of RyR2 clusters, confirming phospho-epitope–specific labeling; WT + H89: attenuated highphos RyR2 cluster sig-
nals. Scale bars: 10 μm; magnified (×4) regions are indicated by yellow brackets. (B) Histogram showing bimodal frequency distribution of in situ pS2808/
RyR2 normalized cluster signals in untreated WT AMs. The main peak indicates abundant lowphos versus fewer highphos RyR2 clusters represented by 
the shoulder. n = 22 AMs. (C) AMs colabeled for Cav3 and RyR2-pS2808. Highphos RyR2-pS2808 clusters alternated with Cav3 clusters in central AT struc-
tures. Scale bar: 10 μm; magnification ×4. (D) Image segmentation confirming highphos RyR2-pS2808 clusters aligned with Cav3-labeled TAT structures. 
(E) WT, RyR2-S2814A+/+, and WT AMs treated with the CaMK inhibitor AIP were coimmunostained for RyR2 and the CaMK-phosphorylated epitope RyR2-
pS2814. Note the central highphos RyR2 clusters (yellow) versus lowphos RyR2 clusters (green). AMs from CaMK phosphorylation–incompetent RyR2-
S2814A+/+ mice showed no CaMK phosphorylation in situ. Magnifcation ×4. (F) Frequency histogram of the pS2814/RyR2 cluster distribution indicating 
abundant lowphos versus few highphos RyR2 clusters in control AMs. n = 19 AMs. (G) AMs coimmunostained for Cav3 and RyR2-pS2814. Highphos RyR2 
clusters were associated with Cav3-labeled AT structures as confirmed by image segmentation (H). Scale bar: 10 μm, magnifcation ×4. (I) STED images 
comparing immunolabeled central RyR2 clusters in VMs versus AMs. Atrial RyR2 clusters identified by red circles show a higher density on Z-lines and 
a trend toward overall shorter NNDs. Images are representative of 18 VMs and 19 AMs. Scale bars: 500 nm. Box and whisker plot: boxes show lower and 
upper quartiles; whiskers represent the 5th and 95th percentiles. IF, immunofluorescence. (J) Confocal live AM imaging with di-8-ANEPPS and fluo-4 show-
ing large AT-localized Ca2+ sparks occurring repeatedly. CaT, final 1-Hz pacing evoked Ca2+ transient; red triangles indicate AT-associated Ca2+ sparks; white 
triangles indicate surface membrane–associated Ca2+ sparks.
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meric RyR2 channel complex (28). Since PKA phosphorylation of 
Ser 2808 and CaMK phosphorylation of Ser 2814 are powerful posi-
tive regulatory mechanisms of RyR2 sensitivity for Ca2+-dependent 
activation (28–30), we investigated the nature of subcellular RyR2 
phosphorylation using novel in situ immunofluorescence strategies.
Using Abs specific to either PKA-phosphorylated RyR2-
pS2808 or CaMK-phosphorylated RyR2-pS2814, we identified 
distinct populations of highly phosphorylated (highphos) RyR2 
clusters in AMs (Supplemental Figure 5A), but not in VMs from the 
same WT mouse hearts (Supplemental Figure 5B). In AMs, central 
highphos RyR2-pS2808 clusters were axially aligned in “string-
of-pearls” arrangements, which regularly intersected with mini-
mally phosphorylated (lowphos) clusters in transversal striations 
at Z-lines (Figure 3A). Molecular labeling specificity was con-
firmed by 2 independent approaches. First, RyR2-pS2808 epitope 
detection was obstructed by the blocking, but not by the control 
peptide, confirming specific phospho-Ab binding (Supplemental 
Figure 6). Second, AMs from mice expressing a PKA phosphory-
lation–incompetent mutation (Ryr2S2808A/S2808A; hereafter referred 
to as RyR2-S2808A+/+–knockin mice) showed complete ablation of 
RyR2-pS2808 in situ cluster signals (Figure 3A).
Since local PKA activity, apparent through highphos RyR2 
cluster phosphorylation, occurred in the absence of β-AR stimula-
tion, we hypothesized that competitive pharmacological PKA inhi-
bition would attenuate TAT-associated PKA activity. Indeed, live 
AMs treated with the cAMP-specific PKA inhibitor H89 (50 μM) 
showed blunted highphos RyR2 cluster signals (Figure 3A). This 
result indicates significant cAMP-dependent local PKA activity, 
sufficient to sustain PKA phosphorylation of highphos RyR2 clus-
ters. Collectively, these data suggest a highly compartmentalized 
form of atrial RyR2 cluster regulation, which may functionally dif-
ferentiate highphos from lowphos RyR2 channel populations.
To quantify the apparently heterogeneous in situ cluster 
phosphorylation, we analyzed the frequency distribution of the 
pS2808/RyR2 normalized cluster signals. Untreated WT AMs 
showed a major pS2808/RyR2  peak, indicating abundant low-
phos clusters (Figure 3B). In contrast, highphos pS2808/RyR2 
signals occurred at much lower frequencies, indicated by a right-
skewed distribution (Figure 3B). VMs isolated from the same 
hearts showed a markedly different distribution (Supplemental 
Figure 5C). To explore whether axially aligned RyR2 highphos 
clusters are associated with AT structures in AMs, we coimmu-
nostained AMs for Cav3 and RyR2-pS2808. This confirmed that 
Cav3-positive ATs were closely aligned with highphos RyR2 sig-
nals in string-of-pearls arrangements (Figure 3C). Furthermore, 
triple staining of Cav3, RyR2, and RyR2-pS2808 confirmed that 
RyR2 clusters that colocalized with Cav3-labeled AT structures 
were indeed highphos clusters (Supplemental Figure 7). In con-
trast, lowphos RyR2 clusters in transverse striations did not colo-
calize with AT or TT components.
Using a corresponding image segmentation strategy, we ana-
lyzed the spatial association of highphos versus lowphos RyR2-
pS2808 clusters with Cav3-labeled TAT structures as the nearest 
neighbor distance (NND) (Supplemental Figure 8A). The NND 
was significantly smaller for highphos than for lowphos RyR2-
pS2808 clusters (Supplemental Figure 8B). We visualized the seg-
mentation analysis output and compared corresponding image 
regions and found that central highphos RyR2-pS2808 clusters 
were tightly associated with Cav3-positive AT structures (Figure 
3D). While highphos RyR2-pS2808 clusters represented the small-
er population in untreated AMs (Figure 3B), our analysis indicated 
their preferential association with AT structures, consistent with 
rapid junctional Ca2+ release at AT sites.
In addition, CaMK phosphorylation of the RyR2-S2814 site 
was identified as a mechanism of AF susceptibility in mice (31, 
32), and both RyR2-S2808 and RyR2-S2814 phosphorylation 
changes were identified in atrial samples from patients with AF 
(33, 34). Consequently, we investigated RyR2-pS2814 phosphor-
ylation in situ, finding axially aligned highphos clusters (Figure 
3E). Confirming phospho-epitope–specific labeling, AMs from 
CaMK phosphorylation–incompetent Ryr2S2814/S2814A-knockin mice 
(referred to herein as RyR2-S2814A+/+-knockin mice) showed 
complete ablation of RyR2-pS2814 cluster signals (Figure 3E). 
Furthermore, pretreatment with the CaMK-specific autoinhibito-
ry peptide (AIP, 5 μM) blunted the RyR2-pS2814 highphos RyR2 
cluster signal in situ (Figure 3E).
The pS2814-RyR2 frequency histogram showed a major peak 
and right-skewed distribution, indicating abundant lowphos and 
few highphos clusters (Figure 3F). Coimmunostaining of AMs for 
Cav3 and RyR2-pS2814 showed that highphos RyR2-pS2814 clus-
ters aligned with AT structures (Figure 3G). While image segmen-
tation of Cav3-labeled TAT structures and highphos RyR2-pS2814 
clusters confirmed this association, some highphos clusters 
showed no TAT association (Figure 3H). And while statistical anal-
ysis of RyR2-pS2814 to Cav3 spacing confirmed a specific correla-
tion (Supplemental Figure 8C), NND analysis did not reach sta-
tistical significance between highphos and lowphos RyR2-pS2814 
clusters using analogous thresholding procedures applied to 
RyR2-pS2808 clusters (Supplemental Figure 8D). Taken together, 
our data on untreated AMs suggest that locally increased CaMK 
activity can maintain RyR2-S2814 cluster phosphorylation at both 
TAT structures and other sites. Thus, both CaMK and PKA phos-
phorylate AT-associated RyR2 clusters in AMs, albeit through dis-
tinct molecular pathways converging locally in highphos clusters.
Large elemental Ca2+ signals at AT sites. Local control of ele-
mental Ca2+ release (Ca2+ sparks) in CRUs may depend on the 
spatial interrelation between RyR2 clusters and AT membranes, 
as proposed previously (7). Using STED nanoscopy, we compared 
intracellular RyR2 cluster densities between AMs and VMs (Figure 
3I). Interestingly, there was a nonsignificant trend (Mann-Whit-
ney U test) toward a smaller yet highly variable NND between 
RyR2 clusters in AMs, suggesting a potentially higher central clus-
ter density (Figure 3I). Since AT structures are significantly larger 
in AMs, their membrane surface may couple more and/or larger 
RyR2 clusters during local Ca2+ release than do TTs, as supported 
by ET and 3D segmentation (Figures 1, D and E).
To explore this hypothesis, we imaged fluo-4–loaded AMs 
costained with di-8-ANEPPS to determine whether Ca2+ sparks 
originate from distinct RyR2 cluster sites. Transversal line scan-
ning during 1-Hz field pacing confirmed earlier central Ca2+ tran-
sient onset (analogous to Figure 1K), followed by unusually large 
post-pacing Ca2+ macro-sparks fired repeatedly from the same AT 
site (Figure 3J). Apparently, Ca2+ sparks originating at the surface 
membrane were smaller. Taken together, CRUs at AT structures 
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Figure 4. Ca2+ macro-sparks at AT sites are reproduced by RyR2 cluster modeling. (A) The final of 5 consecutive Ca2+ transients of a voltage-clamped AM 
(1-Hz pacing) during depolarization from –75 to 0 mV was magnified (corresponding dashed-line boxes) to visualize early Ca2+ signal onset locally. Block 
arrows indicate different Ca2+ spark locations at –50 mV, including off-membrane cytosolic sites (CY). Top 2D traces show Ca2+ spark events at AT, S, and CY 
locations, and examples highlighted by color are magnified by corresponding 3D surface plots (bottom panels): macro-spark (pink), ember (green), classic 
Ca2+ sparks (blue), and regenerative macro-sparks. Dot plot correlating Ca2+ spark full duration at half maximum (FDHM) and full width at half maximum 
(FWHM) to segregate classic (blue) from macro-sparks (green) and embers (pink). (B) Box plots comparing Ca2+ spark amplitude (Amp), FWHM, and FDHM 
in different locations. *P < 0.05, by ANOVA. (C) Atrial Ca2+ spark model composed of 1 transversal RyR2 cluster row. The indicated AT and S structures 
were associated with junctional highphos RyR2 clusters. Each cluster contained 35 RyR2 channels stochastically activated at –50 mV; both highphos and 
lowphos RyR2 clusters initiated SR Ca2+ release. Mathematical modeling generated the stochastic open time profiles of individual RyR2 channels for each 
cluster, which was used to calculate line-scan images of Ca2+ sparks with confocal resolution. Ca2+ sparks presented as 2D-flattened images (top) are high-
lighted by color, and the corresponding 3D surface plots are shown (bottom): classic Ca2+ sparks (blue), macro-spark (green), ember (pink), and regenerative 
macro-sparks (gray). NORyR, number of open RyR2 channels. (D) Box and whisker plots comparing Ca2+ spark amplitude, FWHM, and FDHM as the average 
modeling output. (E) Comparing the aggregate properties of calcium sparks show no significant differences between the AM imaging results and spark 
modeling output. *P < 0.05, by ANOVA (B and D). Box and whisker plots: boxes show lower and upper quartile; whiskers show the 5th and 95th percentiles. 
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repeatedly from AT sites (Figure 4A). In contrast, Ca2+ sparks orig-
inating from non-AT–coupled sites appeared smaller (Figure 4A). 
2D traces and 3D surface plots highlight the different types of Ca2+ 
spark events: macro-sparks (pink), long-lasting sparks (embers; 
green), classic sparks (blue), and regenerative macro-spark Ca2+ 
propagation (Figure 4A, compare color-rendered top and bot-
tom panels). Central Ca2+ macro-sparks, apparently sequentially 
recruited, indicated that several RyR2 clusters may contribute to 
the same Ca2+ release event. The dot plot summarizes the differ-
can generate Ca2+ macro-sparks, suggesting a potential mecha-
nism of local AT-dependent Ca2+ signaling in AMs.
To control LCC activity, voltage-clamped AMs underwent 5 
depolarization cycles to equilibrate the SR Ca2+ load, followed by 
imaging of spontaneously occurring Ca2+ sparks. We used dF/dt 
onset analysis to identify early Ca2+ release sites (as shown in Figure 
1M) and classified the principal Ca2+ spark locations accordingly. 
Following repolarization to –50 mV, Ca2+ macro-sparks, character-
ized by high amplitude, large width, and long duration, originated 
Figure 5. In situ regulation of atrial RyR2 cluster phosphorylation. (A) Illustration showing cAMP-dependent responses of Epac1-camps, a ubiquitous 
cytosolic FRET sensor, during live-cell measurements. In AMs, signals from 4 transversally distributed FRET regions were sampled and signal averaged 
pairwise for corresponding central (2 + 3, red) versus surface (1 + 4, blue) regions. kOFF, cAMP dissociation constant; kON, cAMP association constant; CFP, 
cyan fluorescent protein; YFP, yellow fluorescent protein. (B) FRET ratio traces show the same spatiotemporal AM response to 0.1 μM ISO stimulation 
during increasing intracellular cAMP generation. Bar graph comparing the maximal rate of cAMP rise shows no significant difference between AM center 
and surface. NS, by Student’s t test. n = 12 AMs. (C) Confocal time series showing progressive RyR2-S2808 cluster phosphorylation following up to 60 
seconds of β-adrenergic stimulation (1 μM ISO). RyR2-pS2808 cluster signals were averaged from 10 striations (see magnifications) through equal-sized 
central (red) and surface (blue) regions indicated by dashed-line yellow boxes. RyR2-pS2808 intensity plot shows progressive cluster phosphorylation, 
which was significantly faster for central AM regions after a 20-second ISO stimulation. Each time point represents 7 AM experiments. *P < 0.05,  
**P < 0.01, and ***P < 0.001, by ANOVA. (D and E) Maximal stimulation by combined ISO/RO (1 μM/10 μM) treatment converted lowphos into highphos 
RyR2 clusters. (D) Histogram shows bimodal pS2808-RyR2 cluster signal pattern under control conditions (black trace), resulting in a profound change of 
the lowphos RyR2 cluster signals by ISO/RO treatment: 1 major highphos peak, consistent with complete lowphos cluster conversion (red trace).  
**P < 0.01, by Mann-Whitney U test. Dara are representative of 13 control-treated and 18 ISO/RO-treated AMs. Scale bars: 10 μM, magnification ×4. (E) 
Images and histogram showing a distinct pS2814/RyR2 cluster phosphorylation shift after ISO/RO stimulation (note: control data are the same as in Figure 
3F). *P < 0.05, by Mann-Whitney U test. Data are representative of  19 control-treated and 12 ISO/RO-treated AMs. Scale bars: 10 μM, magnification ×4.
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To assess central cAMP-dependent PKA signaling in AMs, 
we studied the spatiotemporal dynamics of lowphos RyR2 cluster 
recruitment during acute ISO stimulation (1 μM). We analyzed 
RyR2-pS2808 signal intensities on RyR2 cluster striations, compar-
ing central versus surface regions for temporal differences (Figure 
5C). RyR2-S2808 cluster phosphorylation on transversal cluster 
striations was significantly higher 20 seconds after ISO stimulation 
(Figure 5C), similar to the observed cAMP FRET signal dynamics. 
This supports the notion of faster and/or more efficient central 
cAMP–dependent signal transduction inside AMs (Figure 5C).
To maximally recruit RyR2 clusters, we combined β-AR stim-
ulation (1 μM ISO) with selective phosphodiesterase PDE4D inhi-
bition by 10 μM  rolipram (RO). This combined ISO/RO treatment 
converted all lowphos into highphos RyR2-pS2808 clusters, in 
contrast to control AMs treated with carrier solution (Figure 5D). 
Consistent with maximal lowphos RyR2 cluster conversion, ISO/
RO treatment significantly transformed the pS2808/RyR2 cluster 
population signal from a lowphos-dominated peak into a single 
highphos cluster peak (Figure 5D). In addition, ISO/RO treatment 
shifted the pS2814/RyR2 signal peak rightward (Figure 5E). Appar-
ently, the peak RyR2/pS2808 highphos cluster conversion follow-
ing ISO/RO stimulation is more pronounced. These data confirm 
that nonjunctional RyR2 cluster regulation in situ can be explained 
by bimodal cluster behavior through reversible catecholaminergic 
recruitment of the overall larger lowphos RyR2 cluster population, 
through both increased PKA and CaMK phosphorylation.
Since β-AR stimulation is a central inotropic, yet incompletely 
understood, mechanism in the atria, we studied intracellular Ca2+ 
transient behavior during 0.5-Hz pacing. AMs with abundant AT 
structures reproduced the early Ca2+ release profile led by AT site 
activation under control conditions (Figure 6A). ISO/RO-treated 
cells showed profoundly accelerated Ca2+ transients with flattened 
profiles, indicating more even activation of junctional and non-
junctional (CY) Ca2+ release sites (Figure 6A). While the earliest 
Ca2+ release sites were stably associated with either AT or S loca-
tions (shown by di-8-ANEPPS staining), the mean Ca2+ release 
onset was significantly accelerated at S, but not at AT, locations 
(Figure 6A). Thus, analysis of different Ca2+ release locations by 
derivative (dF/dt) showed that the main ISO/RO effect consists 
of accelerated cytosolic Ca2+ release (Figure 6A), compatible with 
nonjunctional lowphos RyR2 cluster recruitment leading to accel-
erated Ca2+ release spread during cAMP-dependent stimulation.
In VMs, cAMP is generated by transmembrane AC5/6, and 
β-AR stimulation represents the major pathway to increase AC5/6 
activity (27). However, this has not been established in atrial 
muscle. We confirmed similar AC5/6 protein expression levels 
in murine atrial and ventricular tissue (Figure 6B). Interestingly, 
expression of the PKA catalytic subunit (PKA-C) was significant-
ly higher in the atria (Figure 6B and Supplemental Figure 10), 
correlating with more robust PKA-C striations in AMs compared 
with those observed in VMs (Supplemental Figure 11). Since RyR2 
channels and PKA-C were shown to colocalize in situ at Z-line 
striations (based on previous cAMP FRET measurements; ref. 
28), and since the central RyR2 cluster density may be higher in 
AMs (Figure 3I), our data suggest an increased atrial capacity for 
cAMP-dependent regulation of RyR2 clusters. Indeed, immuno-
blots confirmed that the maximal change of substrate-normalized 
ent types (grouped by colors, as above) of Ca2+ signals originating 
from AT sites: classic sparks, macro-sparks, and embers (Figure 
4A). Comparison of the mean width and duration at different sub-
cellular locations showed that Ca2+ macro-sparks originated more 
frequently from ATs (Figure 4B). This suggests that AT junctions 
can repeatedly generate Ca2+ macro-sparks and embers, generally 
coordinating larger local Ca2+ release events.
Quantitative RyR2 cluster modeling supports local and global AT 
coupling. To integrate the observed local and global Ca2+ signals 
mechanistically, we used an existing mathematical ECC mod-
el that incorporates the latest biophysical information regarding 
local RyR2 cluster dynamics (35). This model was modified to 
account for our data on AT-associated Ca2+-signaling functions 
and discrete localizations of highphos RyR2 clusters at AT and 
S sites (Figure 4C). We built a 3D model of CICR within a single 
AM sarcomeric Z-region (M-line to M-line) containing CRUs with 
either lowphos or highphos RyR2 clusters (n = 35 RyR2 channels 
each), randomly arranged transversally to simulate AT-associated 
Ca2+ signals recorded in line-scan mode. RyR2 clusters, sponta-
neously activated by the local diadic subspace [Ca2+]ds concentra-
tion or by LCC openings at the –50 mV holding potential, produced 
corresponding Ca2+ sparks and localized depletions in junctional 
SR Ca2+ concentration ([Ca2+]jSR) termed Ca2+ blinks (Supplemen-
tal Figure 9). Detailed visualization of the simulated Ca2+ spark 
behaviors and their spatiotemporal dimensions showed that Ca2+ 
macro-sparks and embers could be elicited in the model from AT 
highphos RyR2 clusters (Figure 4C). Systematic Ca2+ spark com-
parisons showed a significantly increased Ca2+ spark amplitude 
at AT sites and reproduced Ca2+ spark dimensions distinct from 
those at cytosolic and subsarcolemmal sites (Figure 4D). Average 
Ca2+ spark dimensions were quantitatively reproduced by com-
putational modeling (Figure 4E). Thus, mathematical modeling 
supports the plausibility of a new Ca2+-signaling mode, where-
by AT-associated structures constitutively regulate atrial ECC 
through highphos RyR2 clusters, locally increasing the sensitivity 
for Ca2+-dependent activation as a basis for Ca2+ macro-spark gen-
eration and local Ca2+ transient onset.
β-AR stimulation recruits nonjunctional RyR2 clusters. Lowphos 
RyR2 clusters might be selectively recruited during β-AR stimula-
tion, as opposed to highphos clusters constantly saturated by tonic 
local PKA and CaMK phosphorylation. To characterize intracellu-
lar cAMP concentration changes in real time, we used transgenic 
mice that express a ubiquitous cytosolic fluorescence resonance 
energy transfer (FRET) sensor, Epac1-camps (36) (Figure 5A). 
Pairwise regional FRET sampling in AMs during isoproterenol 
(ISO) stimulation was used to detect central versus peripheral 
cAMP concentration changes (Figure 5A). The resulting traces, 
each from central and peripheral regions, showed comparable 
robust FRET signal responses as judged by the maximal amplitude 
of the intracellular cAMP rise after approximately 20-second ISO 
stimulation (Figure 5B). Also, the maximal rate of the cAMP rise 
(dF/dt) was not different between central or peripheral AM regions 
(Figure 5B). Given that cytosolic cAMP movement, at least in VMs, 
is much slower than free diffusion (37) and that principally sim-
ilar cAMP concentration changes were present in the center and 
periphery of AMs, our data support a central, potentially AT-asso-
ciated cAMP-generating mechanism.
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by approximately 4-fold, suggesting decreased stoichiometric 
SERCA2 inhibition in atria (12, 16). We confirmed significantly 
higher SERCA2 levels, but since PLN levels were  approximate-
ly 10-fold lower, the resulting PLN/SERCA2 ratio in mouse atria 
was reduced by approximately 50-fold compared with the ratio 
in ventricles (Figure 6B). Consequently, ISO/RO treatment 
induced only remote phosphorylation changes of PLN-S16. 
Overall, these data indicate a minor regulatory role of PLN for 
SERCA2 function in AMs (Figure 6B).
Since SERCA2 activity determines the SR transmembrane 
Ca2+ gradient underlying SR Ca2+ release, we measured steady-
state Ca2+ transients during pacing. Consistent with previous 
studies (16), Ca2+ transients in mouse AMs showed significantly 
higher amplitudes and faster rise and decay rates compared with 
VMs (Supplemental Figure 13). We assessed the SR Ca2+ load by 
caffeine application (10 mM) and found an approximately 2-fold 
higher amplitude of the Ca2+ transient in AMs versus that in VMs 
(Figure 6D), consistent with previous observations in rat AMs (16). 
RyR2-S2808 phosphorylation by PKA (Figure 6B) and RyR2-S2814 
by CaMK (Figure 6C and Supplemental Figure 12, A and B) during 
ISO/RO treatment was significantly higher in AMs compared 
with that detected in VMs. In contrast, acute pharmacological ISO 
stimulation using a low nanomolar concentration (20 nm) result-
ed in a significant change in RyR2-S2808 phosphorylation, but 
no change in RyR2-S2814 phosphorylation (Supplemental Figure 
12C). Taken together, our data indicate that synergistic regulation 
of lowphos RyR2 clusters by both PKA and CaMK occurs during 
maximal sustained cAMP generation through a highly efficient 
regulatory mechanism in AMs, with the potential for complete 
lowphos-to-highphos RyR2 cluster conversion.
Earlier data from rat hearts showed that phospholamban 
(PLN), an inhibitor of SR Ca2+ (SERCA2) pump function released 
by PKA phosphorylation of PLN-S16, is expressed at significant-
ly lower levels in AMs than in VMs (16). In addition, SERCA2 
expression is approximately 2-fold higher in AMs compared 
with expression in VMs, while the PLN/SERCA2 ratio is reduced 
Figure 6. Catecholaminergic stimulation accelerates atrial Ca2+ signaling. (A) Live imaging of AT and S membrane structures during Ca2+ transient onset in 
control- versus ISO/RO-treated AMs (0.5-Hz pacing). ISO/RO treatment accelerated transversal Ca2+ release propagation across the cytosol, compressing 
the F25 profile through a decreased cytosolic (CY) latency of early Ca2+ release (dF/dt). Data are representative of 9 control- and 17 ISO/RO-treated AMs. 
**P < 0.01 and ***P < 0.001, by Student’s t test. (B) Immunoblots comparing ISO/RO-treated (1 μM/10 μM) atrial (A) tissue from WT and phosphoryla-
tion-incompetent RyR2-S2808A+/+ mouse hearts; ventricular (V) tissue was compared for reference. In WT atria, significantly higher expression levels of 
both PKA-C and SERCA2 were detected, in contrast to significantly lower PLN levels. Atrial versus ventricular PKA phosphorylation changes were signifi-
cantly increased for the RyR2-S2808 site, but not for the PLN-S16 site. Note the similar AC5/6 and RyR2 protein levels. Blots are representative of 3 indi-
vidual experiments (see Supplemental Figure 10 for uncut blots). (C) Analogous RyR2-S2814–specific immunoblotting established in CaMK phosphoryla-
tion–incompetent RyR2-S2814A+/+ mouse hearts (see also Supplemental Figures 12A and 12B). Bar graph shows a significantly increased atrial RyR2-S2814 
phosphorylation change in atrial tissue after ISO/RO (1 μM/10 μM) treatment. (D) SR Ca2+ load was significantly higher in AMs than in VMs measured with 
caffeine (10 mM). n = 8 AMs, 9 VMs. *P < 0.05 and ***P < 0.001, by Student’s t test.
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always greater in AMs (Figure 7A). In contrast, PKA inhibition by 
H89 (1 μM) decreased the sarcomere-shortening amplitude and 
Vmax compared with that observed in untreated AMs (Figure 7A).
To investigate PKA-dependent SR Ca2+ uptake, we studied 
AMs from PLN-KO (Pln–/–) mice with constitutively upregulated 
SERCA2 function. While the shortening amplitude was not sig-
nificantly different in Pln–/– AMs compared with that of ISO-stim-
ulated AMs, the Vmax was significantly smaller and similar to that 
of control WT AMs (Figure 7A). In summary, PLN ablation had no 
significant effect on sarcomere shortening compared with unstim-
ulated AMs, consistent with the overall low atrial PLN protein 
expression levels in AMs.
To probe the functional role of RyR2 channel phosphory-
lation, we analyzed AMs from PKA phosphorylation–incompe-
tent RyR2-S2808A+/+ and CaMK phosphorylation–incompetent 
RyR2-S2814A+/+-knockin mice. Compared with WT cells, both 
RyR2-S2808A+/+ and RyR2-S2814A+/+ cells exhibited significantly 
decreased shortening amplitude and Vmax under basal (Figure 7A) 
Both protein expression and Ca2+ transient data support a model 
of constitutively high SERCA2 function in atria. Hence, lowphos 
RyR2 cluster recruitment during catecholaminergic stimulation 
may represent a major and potentially cell-specific regulatory 
mechanism of SR Ca2+ cycling in atria.
Catecholaminergic RyR2 cluster recruitment regulates atrial sar-
comere shortening. The characteristic Ca2+ transient profiles we 
observed in AMs may support cell type–specific sarcomere short-
ening behavior. More specifically, rapid activation of ECC at base-
line might be augmented by β-AR stimulation axially and transver-
sally through faster recruitment of sarcomeres near lowphos RyR2 
clusters. First, we measured the maximal sarcomere-shortening 
amplitude and velocity (Vmax) under baseline and ISO-stimulated 
conditions in mechanically unloaded WT cells. Sarcomere-short-
ening amplitude was significantly higher in ISO-treated AMs 
compared with that of control AMs or ISO-treated VMs (Figure 
7A). Whereas ISO (1 μM) significantly increased the shortening 
amplitude and Vmax in both VMs and AMs, the absolute level was 
Figure 7. Catecholaminergic RyR2 cluster recruitment regulates sarcomere shortening and atrial contractility. (A) Representative AM sarcomere length 
traces during unloaded shortening; colors at top indicate the different conditions; VMs were used as a reference. The same WT AM control trace (black) is 
presented twice for comparison. WT AMs were treated with ISO (1 μM) or H89 (1 μM) and compared with RyR2-S2808A+/+-knockin, RyR2-S2814A+/+–knock-
in, or PLN-KO (Pln–/–) strains. Bar graphs summarizing maximal sarcomere shortening amplitude and velocity (Vmax) for the indicated conditions. Data are 
representative of 29 VMs and 59 AM WT controls; ISO, 13 AMs; H89, 33 AMs; S2808A, 44 AMs; S2814A, 36 AMs; and PLN, 17 AMs. *P < 0.05, **P < 0.01, 
and ***P < 0.001, by Student’s t test. (B) LA echocardiogram showing normal LA diameters in diastole versus systole (arrows) but significantly decreased 
fractional shortening in RyR2-S2808A+/+ mice. An electrocardiogram (ECG) recording (green) was used to time maximal atrial relaxation and contraction 
(triangles). n = 18 WT mice and 19 RyR2-S2808A mice+⁄+. *P < 0.05, by Student’s t test. Ao, aorta; asterisk indicates the aortic valve. Scale bars: 1 mm. (C) 
Confocal live-image overlays were aligned to the left-most striation as indicated. The flexible nature of the sarcomeric M-bands was visualized during AM 
contraction (red) versus relaxation (green) using knockin mice expressing C-terminal–tagged titin-EGFP and peripheral versus central readouts as indicat-
ed. Bar graphs summarize the relative M-band latency between peripheral (P) versus central (C) M-band regions in control- versus ISO-treated (1 μM) cells. 
n = 29 control and 24 ISO AMs. ***P < 0.001, by Student’s t test.
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lation–incompetent RyR2 channels exhibited normal LA diastol-
ic diameters, fractional shortening was decreased (Figure 7B). 
Hence, genetic ablation of RyR2 PKA phosphorylation is sufficient 
to cause significant loss of atrial function in vivo, presumably 
through depressed sarcomere shortening in AMs.
Since the M-band is generally considered a relatively elastic 
transversal sarcomere structure, we hypothesized that systolic 
M-band deformation could correlate with the Ca2+ transient pro-
and ISO-stimulated (1 μM) conditions (data not shown). While 
both RyR2-knockin models showed decreased shortening and Vmax 
under basal conditions, the absolute decrease was significantly 
greater in RyR2-S2808A+/+ cells (Figure 7A). Given the more pro-
nounced effect on sarcomere function in RyR2-S2808A+/+ cells, 
we used LA echocardiography to explore the functional relevance 
of highphos RyR2 cluster ablation in vivo in RyR2-S2808A+/+ mice. 
While age-matched RyR2-S2808A+/+ mice with PKA phosphory-
Figure 8. Atrial hypertrophy causes AT proliferation and faster Ca2+ release activation. (A) Echocardiography confirmed significant changes in atrial size 
and contractile function after TAC. n = 19 sham mice and 21 TAC-treated mice. **P < 0.01 and ***P < 0.001, by Student’s t test. (B) Confocal line-scan 
images correlating local Ca2+ transient onset with membrane structures versus cytosolic locations in paced AM from the left atrium (0.5 Hz). Compared with 
sham-treated mice, the post-TAC latency of SR Ca2+ release was significantly decreased at off-membrane CY locations. n = 16 sham-treated AMs, 22 TAC 
AMs. ***P < 0.001, by Student’s t test. (C) Confocal TAT imaging in live AM from the left atrium of sham or TAC hearts. After TAC, TAT skeletons (magenta) 
show proliferative changes, as quantified by TAT component analysis in hypertrophied LA AMs. Histogram subtraction (TAC – sham) demonstrated differen-
tial post-TAC changes: increased AT (0°) versus decreased TT components (90°). Bar graph summarizes significantly increased post-TAC AT/TT ratio (binning 
± 10°). n = 34 sham-treated AMs and 44 TAC-treated AMs from 3 to 4 hearts each. ***P < 0.001, by Student’s t test. Scale bars: 10 μm, magnification ×4. (D) 
Immunoblots from atrial tissue lysates of sham- and TAC-treated hearts. Protein expression and phosphorylation changes are summarized by bar graphs. 
Blots are representative of 3 independent experiments. *P < 0.05 and **P < 0.01, by Student’s t test. (E) Confocal images of AM from the left atrium show-
ing increased highphos RyR2 cluster abundance in more numerous central-axial string-of-pearls in hypertrophied post-TAC as compared to sham-treated 
AM. Bar graphs summarize significance for an increase in cell size, a decrease in RyR2 cluster density, and an increase in the highphos RyR2-pS2808 cluster 
fraction after TAC. n = 33 sham-treated and 46 TAC-treated AMs. ***P < 0.001, by Student’s t test. Scale bars: 10 μm, magnification ×4. 
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in TT (90°) components in hypertrophied AMs after TAC (Figure 
8C). Consequently, the post-TAC AT/TT ratio was significantly 
increased (Figure 8C). Notably, while atrial hypertrophy leads to 
select proliferation of AT components, this occurs on the back-
ground of significantly increased cell dimensions (Supplemental 
Figure 14D). Since AT structures couple highphos RyR2 clusters 
to rapid Ca2+ release in AMs, we next sought to analyze proteomic 
and in situ RyR2 cluster changes.
Immunoblotting showed significantly decreased post-TAC 
RyR2 protein levels (Figure 8D). Since RyR2 expression was not 
changed in LV tissue (data not shown), the observed post-TAC 
RyR2 channel downregulation appeared to be atria specific. Fur-
thermore, PKA phosphorylation was significantly increased at 
the RyR2-S2808 phosphorylation site, but not at the CaMK phos-
phorylation site RyR2-S2814, in atrial tissue (Figure 8D). In con-
trast, 4 weeks after TAC in ventricular tissue, RyR2-S2814, but not 
RyR2-S2808, phosphorylation was substantially increased (data 
not shown), confirming an earlier study (39) and supporting the 
presence of atria-specific RyR2-S2808 phosphorylation changes. 
PKA hyperphosphorylation of RyR2 is known to increase the sensi-
tivity for Ca2+ activation, which is generally consistent with altered 
cytosolic SR Ca2+ release in post-TAC AMs (Figure 8B). Additional-
ly, decreased SERCA2 expression increased the PLN/SERCA2 ratio 
and may have depressed post-TAC SR Ca2+ uptake in AMs (Figure 
8D). Of note, increased SR Ca2+ release in the context of increased 
RyR2 phosphorylation and decreased Ca2+ uptake may increase the 
propensity for cytosolic Ca2+ overload at higher heart rates.
In atrial hypertrophy with increased post-TAC AT prolifera-
tion, a parallel increase of highphos RyR2 clusters occurred, along 
with more numerous axial-central strings heterogeneously dis-
tributed across thicker AM cells from the left atrium (Figure 8E). 
Using isolated AMs from the LA of TAC hearts, we confirmed a 
significantly increased post-TAC hypertrophic cell size compared 
with sham-treated cells (Figure 8E and Supplemental Figure 14D). 
However, despite the observed increase in highphos RyR2 cluster 
strings, the cell-wide density of all RyR2 clusters (both lowphos 
and highphos) was significantly decreased after TAC (Figure 8E), 
in agreement with the observed decrease in RyR2 protein expres-
sion levels. Yet, the AM-specific fraction of highphos RyR2-pS2808 
clusters was significantly increased (Figure 8E). This indicates a 
relatively strong increase in highphos, at the cost of a reduced low-
phos RyR2 cluster population and can explain the observed Ca2+ 
transient changes through earlier nonjunctional cluster recruit-
ment, contributing to overall rapid Ca2+ transient onset, as observed 
throughout hypertrophied AMs (Figure 8B). Taken together, the 
activation of SR Ca2+ release through more numerous AT structures 
and through an increased highphos RyR2 cluster fraction contrib-
utes to accelerated recruitment and earlier activation of adjacent 
nonjunctional lowphos clusters, indicating a sustained mechanism 
of subcellular Ca2+ transient adaptation in hypertrophied AMs, 
despite significantly decreased RyR2 channel expression.
Discussion
Here, we identify an atrial ECC “super-hub” mechanism that is 
based on a highly specialized membrane-protein network char-
acterized by: 1) tubular membrane structures (ATs) with axial 
orientations that are 2) abundant in AMs and 3) connected to the 
files observed in AMs. To assess this, we imaged EGFP-labeled 
M-band striations using AM from knockin mice that express a 
C-terminally tagged titin-EGFP fusion protein (38). We found a 
significant transversal latency difference between peripheral and 
central M-band deformations during sarcomere shortening in live 
AMs under baseline conditions (Figure 7C; compare Supplemen-
tal Videos 1 and 2 or Supplemental Videos 3 and 4). Consistent 
with transversal lowphos-to-highphos RyR2 cluster conversion, 
acute ISO (1 μM) stimulation curtailed the M-band–specific laten-
cy difference (Figure 7C). The blunted M-band latency difference 
corresponded to the accelerated Ca2+ release spread observed in 
ISO/RO-stimulated AMs (Figure 6A).
We thus identified the following features of atrial sarco-
mere regulation: 1) axial sarcomere shortening is constitutively 
increased through tonic highphos RyR2 cluster regulation in AMs, 
contributing to rapid Ca2+ transient onset through AT-coupled 
highphos RyR2 clusters at baseline; 2) β-AR stimulation signifi-
cantly increases sarcomere shortening and reduces transversal 
latency differences during sarcomere contraction.
Atrial hypertrophy causes AT proliferation, leading to acceler-
ated cytosolic Ca2+ release. Atrial hypertrophy has been linked to 
depressed atrial contractility in patients and represents an import-
ant risk factor for AF, thromboembolic stroke, and HF. However, 
the mechanisms leading from atrial hypertrophy (frequently asso-
ciated with systemically increased blood pressure) to contractile 
dysfunction, in particular prior to and/or independently of AF, 
remain unclear. We used a model of transaortic constriction (TAC) 
in mice to induce hypertrophy of the LA. Four weeks after TAC, 
echocardiography confirmed significantly increased LA inner 
diameters and decreased fractional LA shortening (Figure 8A and 
Supplemental Table 2). Furthermore, increased hypertrophic wall 
thickening (left ventricular anterior wall thickness in diastole [LV 
AWTh]) and increased heart weight (HW/BW) were observed 
(Supplemental Table 2). Histological analysis confirmed that TAC 
induced significant LA hypertrophy and dilation, but showed no 
right atrial (RA) pathology (Supplemental Figure 14, A–C).
To explore potential atrial mechanisms of contractile dys-
function, we analyzed AT-dependent Ca2+ transient behavior 
using transversal line scanning of AM from the left atrium of 
sham-operated and TAC hearts. Hypertrophied AMs from TAC 
hearts showed more numerous AT structures and considerably 
compressed Ca2+ transient latency profiles, indicating accelerated 
cytosolic Ca2+ release in post-TAC AMs (Figure 8B). Analysis of the 
Ca2+ transient latency profiles (dF/dt) showed that off-membrane 
CY sites contributed significantly to the accelerated cytosolic Ca2+ 
release spread after TAC compared with that seen in sham AMs 
(Figure 8B). Hence, post-TAC cells are characterized by signifi-
cantly accelerated cytosolic Ca2+ release through nonjunction-
al RyR2 cluster sites that are apparently activated through more 
numerous AT structures in substantially thicker AMs.
To elucidate hypertrophic changes in AT structures after TAC, 
we performed live-cell confocal membrane imaging. Hypertro-
phied AM from the left atrium showed an extensive proliferative 
adaptation of their TAT network compared with sham AMs (Figure 
8C). For comparative TAT network analysis, the difference inte-
gral of all TAT component orientations was plotted for post-TAC 
minus sham, highlighting an increase in AT (0°) and a decrease 
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face membrane. Since AT structures and axial junctions are ideal-
ly positioned to activate myofilaments at the AM center, highphos 
RyR2 cluster activation can efficiently support fast activation of 
central sarcomeres in AMs, which would be unlikely if U-shaped 
Ca2+ transients with a delay of approximately 100 ms (7) were to 
control ECC in AMs. Indeed, we found that central myofilaments 
are activated significantly earlier than are peripheral myofila-
ments, given the M-band striation changes in living AMs visual-
ized by titin-EGFP knockin. Taken together, both the earlier acti-
vation of central Ca2+ release through ATs and the faster central 
sarcomere activation observed in AMs agree with the generally 
faster ECC of atrial muscle strips observed previously (12).
Our use of voltage-clamp and EGTA (1 mM) Ca2+ buffering 
allows us to conclude that electrical transmission via the TAT 
network underlies the more rapid ECC activation of AT-coupled 
junctional RyR2 clusters. Here, we identify highly and stably phos-
phorylated RyR2 clusters, which are to a large degree associated 
with AT membranes. At the RyR2 clusters, combined PKA and 
CaMK phosphorylation of RyR2-S2808 and RyR2-S2814, respec-
tively, significantly increases the sensitivity of the Ca2+-dependent 
activation of RyR2 (29, 30, 43). Consequently, junctional AT cou-
plons are ideally positioned to rapidly initiate local SR Ca2+ release, 
as evidenced by Ca2+ macro-sparks. Furthermore, we show that 
nonjunctional SR locations contribute a functionally important 
and economic form of “inotropic reserve,” accessible through 
cAMP-dependent recruitment of lowphos RyR2 clusters and rep-
resenting the first example, to our knowledge, of a differential reg-
ulatory mechanism of this protein in distinct SR domains.
We observed a high level of SR Ca2+ load in mouse AMs under 
baseline conditions, consistent with earlier observations (16). 
Within the context of highphos versus lowphos RyR2 clusters, 
a high SR Ca2+ content against the background of PLN-deficient 
AMs can explain the significantly larger central Ca2+ transient 
amplitude observed at baseline. Accordingly, we confirmed that 
SERCA2 protein levels were approximately 2 times higher in 
mouse atria than in ventricles, which was previously shown to 
stabilize Ca2+ cycling in ratAM (16). Importantly, minimal PLN 
protein levels in mouse atria resulted in a very low PLN/SERCA2 
ratio. This is consistent with an earlier study showing that the tran-
scription factor COUP-TFII suppresses PLN transcription in atria 
(44). Therefore, PKA-dependent recruitment of lowphos RyR2 
clusters may represent a main inotropic SR regulatory mechanism 
in AMs. Indeed, PLN ablation did not significantly change the 
amplitude of sarcomere shortening in AMs from Pln–/–-KO mice.
Using a simplified mathematical model of atrial Ca2+ sparks, 
we were able to reproduce the macro-spark behavior observed at 
the AM center, on the basis of stochastic RyR2 gating of lowphos 
and highphos clusters. As has been established before, the control 
of RyR2 sensitivity to cytosolic [Ca2+]i appears to depend on mul-
tiple factors and interactions. Recent investigations suggest that 
Ca2+ in the SR lumen ([Ca2+]jSR) may exert a nonlinear action on 
the sensitivity of the RyR2 clusters to be triggered (45, 46). Thus, 
a higher [Ca2+]jSR can underlie Ca2+ sparks, with a greater total 
amount of Ca2+ released per average event. Ca2+ macro-sparks 
may facilitate the local propagation of CICR, originating from 
axial couplons. The atrial super-hub provides a new concept, on 
the background of predominant expression of fast α-myosin heavy 
surface membrane through sparse TT components; 4) significant-
ly larger-diameter AT structures compared with TT structures in 
AMs; 5) AT-coupled large junctional RyR2 clusters that are highly 
phosphorylated by PKA and CaMK and arranged in axial string-
of-pearls; 6) triggering by ATs of rapid Ca2+ release from axial 
highphos RyR2 cluster couplons in AMs via Cav1.2 channels; and 
both 7) rapid central Ca2+ transient onset and 8) central Ca2+ mac-
ro-sparks that are activated via junctional highphos RyR2 clusters 
at AT sites. While these observations present a robust intracellular 
context for rapid Ca2+ signaling in AMs, they also lay the founda-
tion for novel and, most important, atria-specific regulatory ECC 
mechanisms. Given the relevance and functionality of the mem-
brane-protein network detailed above, we propose a signaling 
super-hub model that is structurally based on unusually large AT 
and axial couplon dimensions and that may change our perspec-
tive on cell-specific control mechanisms of atrial Ca2+ signaling 
and contractile regulation.
Our observations are supported by previously described ded-
icated AM isolation and high-resolution imaging workflows (18, 
40), which led to our finding of preserved centrally located AT 
structures within TAT networks. Since AMs are generally thinner 
than VMs, it has been proposed that TTs are not needed for ECC 
in these cells (8, 19). However, when we normalized the total TAT 
network length to the cell area, we found AMs with intermediate 
(Figure 1B) rather than low or zero TAT densities, as previously 
reported in rodents (8). Furthermore, we found voluminous AT 
structures that were electrically connected to the surface sarco-
lemmal membrane, presumably via more sparsely present TTs. 
While overall similar, TAT structures were shown previously in a 
minority of cells isolated from atria (7, 41). Here, we identify ATs 
as regularly present and specific structural components that are 
key to ECC in AMs.
Novel cell-specific properties: highly phosphorylated RyR2 clusters 
and SR load tune Ca2+ release at AT locations. In living AMs, STED 
revealed that central RyR2 clusters may be spaced more tightly 
along Z-lines than are those in VMs. We show that the vast major-
ity of transversely oriented RyR2 cluster striations have no near-
by TT membrane and are therefore not triggered by the opening 
of local LCC. In theory, an increased density of transverse RyR2 
clusters would allow a CICR signal from the lateral cell surface to 
activate its nearest neighbor cluster more efficiently during the 
inward propagation of a Ca2+ wave, as shown by previous mathe-
matical modeling (19). However, we found that cellular depolar-
ization elicited Ca2+ transients significantly earlier at AT locations 
than at nonjunctional cytosolic cluster sites, or even at the AM sur-
face. AM activation near the center of the cell has been observed 
and reported as irregular Ca2+ transients (7), but the physiological 
significance of this has not been appreciated, so that central RyR2 
cluster ECC mechanisms remained undefined (42). According-
ly, the approximately 2-μm-wide gap separating surface-coupled 
peripheral RyR2 clusters from central RyR2 clusters was assumed 
to delay activation of the latter and to contribute to U-shaped Ca2+ 
activation in AMs (19). While we can confirm the peripheral RyR2 
cluster gap in AMs (Figures 3, A and E), an exclusive dependence 
of ECC on peripheral clusters seems unlikely. Instead, deep inside 
AM, Ca2+ release is activated via AT depolarization, which occurs 
approximately 2 times faster compared with clusters near the sur-
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for the identification of early atrial disease mechanisms and, ulti-
mately, for AM-directed treatment approaches.
Methods
Additional information is provided in the Supplemental Methods.
Mouse cells. AMs and VMs were isolated from adult mouse hearts 
using collagenase and protocols tuned to preserve subcellular struc-
tural integrity, as previously described (9, 18). RyR2-S2814A+/+-knock-
in mice were provided by Xander H.T. Wehrens (Baylor College of 
Medicine, Houston, Texas, USA); and PLN-KO mice were provided 
by Despina Sanoudou (University of Athens, Athens, Greece). Unless 
indicated otherwise, the genetic background was C57BL/6N.
Human cells and tissues. Atrial tissue samples were obtained from 
patients with sinus rhythm during bypass surgery, following written 
informed consent from the patients. Cell isolation (n = 5) occurred from 
atrial tissue by protocols described previously (49). Cells were plated on 
laminin-coated coverslips for immunofluorescence staining. For IHC, 
LA tissue was fixed in 4% paraformaldehyde (PFA), embedded in paraf-
fin, cut into 4-μm-thick sections, deparaffinized, rehydrated, and anti-
gens unmasked in 10 mM sodium-citrate buffer prior to Ab incubation.
Live-cell confocal microscopy. Confocal images were acquired with 
a Zeiss LSM 710 NLO microscope using a Plan-Apochromat 63x/1.40 
oil objective and a pixel size of 100 nm. Myocytes attached to lami-
nin-coated slides were stained with 50 μM di-8-ANEPPS (Molecular 
Probes) for 15 minutes, washed twice, excited at 488 nm, and emitted 
light detected above 510 nm as previously described (9). TAT networks 
in AMs and VMs were visualized using identical settings. Intracellular 
Ca2+ imaging with fluo-4–AM was combined with di-8-ANEPPS as 
described previously (9). For Ca2+ spark imaging and signal analysis, 
we used previously established protocols (50). Further details on the 
TAT component analysis, Ca2+ transient analysis, or patch-clamping 
are available in the Supplemental Methods.
Live cell STED microscopy. For super-resolution imaging of select 
TAT membrane tubules, we used a customized STED system and Mat-
lab (The MathWorks) algorithms as described previously (9, 18). Fur-
ther details are provided in the Supplemental Methods.
ET. AT and TT structures and isolated AM were preserved by 
high-pressure freezing with an HPM100 system (Leica) as described 
previously (51). ET at the Electron Microscopy core facility at the Euro-
pean Molecular Biology Laboratory (EMBL) Heidelberg (Heidelberg, 
Germany) and at the EM services of the University of Colorado Boulder 
(Boulder, Colorado, USA) was performed as described previously (23).
Pharmacological assays. AMs plated on laminin-coated coverslips 
were pretreated with 10 μM RO dissolved in DMSO (Sigma-Aldrich) 
for 3 minutes, followed by 1 μM ISO (Sigma-Aldrich) for 10 minutes 
(ISO/RO). For Western blot analysis, mouse hearts were Langendorff 
perfused as described above, followed by immediate tissue freezing. 
For acute β-AR stimulation, 1 μM ISO was used if not stated otherwise. 
For in situ PKA inhibition, AMs were incubated for at least 15 minutes 
with H89 (Sigma-Aldrich). For in situ CaMK inhibition, cells were 
treated with 5 μM AIP (Sigma-Aldrich) for 30 minutes.
FRET measurements. In AMs from mice expressing the Epac1-
camps FRET biosensor, intracellular cAMP was assessed during 0.1 
μM ISO treatment as previously described (36). Additional details are 
provided in the Supplemental Methods.
Sarcomere shortening. Sarcomere shortening measurements used 
high optical contrast imaging according to the manufacturer’s instruc-
chain in atria, for both the rapid onset and extent of AM contrac-
tion, the potential for physiological regulation, and altered high-
phos RyR2 cluster function in hypertrophy.
Alterations of axial couplon function in atrial disease. In rabbit 
AM after 5 days of rapid atrial pacing RyR2 protein expression was 
reduced by 50% (4), similar to our observations in mouseAM post-
TAC (Figure 8D). This has given rise to the concept of a physiolog-
ical antiarrhythmic adaptation (Ca2+-signaling silencing), attribut-
ed to a failure of central CICR due to reduced RyR2 channel 
numbers per cluster and despite RyR2-S2808 hyperphosphoryla-
tion (4). In contrast, after TAC, we found an additional decrease 
of approximately 30% in RyR2 cluster density, yet identified an 
increase of highphos RyR2 clusters in more numerous strings, 
which contributed to an approximately 2-fold increase in the 
highphos RyR2 cluster fraction. This suggests the presence of an 
adaptive mechanism that sustains cytosolic Ca2+ release through 
AT-coupled central RyR2 clusters after TAC, in stark contrast to 
the reported tachypacing-induced failure of central Ca2+ signal 
propagation (4). As hypertrophy and reduced contractility were 
identified in canine atria as early as 2 days after pacing (5), it will 
be important for future studies to explore the precise time course 
of transition from normal to hypertrophied atria. In contrast to 
our post-TAC model, a tachypacing HF model of persistent AF in 
sheep showed a complete loss of atrial TAT structures, consistent 
with advanced HF (20, 47). While we examined the LA response 
to TAC-induced atrial hypertrophy in the absence of any obvious 
arrhythmias (data not shown), the adaptive response was a pro-
found increase in AT components, highphos RyR2 clusters, and 
increased nonjunctional Ca2+ release.
Clinical relevance of atrial super-hubs. The use of STED nanos-
copy and ET, combined with membrane-preserving workflows, 
has enabled visualization of AT structures throughout AMs. 
Instead of the TAT being absent in AMs as previously suggested 
(6, 20), we found that a robust and functionally relevant tubular 
membrane system was present in every AM studied. In mouse 
and human AMs, AT membrane structures are an essential com-
ponent of axial couplons that contain extended RyR2 clusters. 
The functions of this complex assembly, described as super-hubs, 
are likely to play important roles in modulating atrial ECC, dis-
tinct from classic couplons in VMs. In contrast, RyR2 PKA phos-
phorylation is significantly increased in patients with chronic AF 
(33) and after short-term tachypacing (4). Both RyR2 single-chan-
nel function and PKA phosphorylation were partially normalized 
in ventricular samples from HF patients treated with β-AR block-
ers (48). Since β-AR blockers are used in approximately 90% of 
patients with AF (2), our finding of a super-hub mechanism of 
contractile regulation in AMs through highphos RyR2 clusters 
may be instrumental in specifically targeting the (side) effects 
of GPCR-targeted drug compounds including β-AR blockers or 
currently available CaMK inhibitors on atrial contractility. Future 
work will need to examine the diverse functional roles of axial 
couplons and changes in RyR2 cluster regulation of hypertrophy 
in atrial cells, tissues, and the heart in vivo. The causal relation 
between highphos RyR2 clusters and rapid atrial contractile acti-
vation, identified through RyR2 phosphorylation–incompetent–
knockin animals, and the sustained structural and metabolic 
adaptation mechanisms in hypertrophy strengthen the rationale 
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tive 2010/63/EU of the European Parliament and of the Council of 
the European Union, Strasbourg, France and in keeping with NIH 
guidelines. All animal procedures were reviewed by the IACUC and 
approved by the Veterinarian State Authority (LAVES, Oldenburg, 
Germany). All protocols were approved by the ethics committee of the 
University Medical Center Göttingen.
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tions (IonOptix). To measure transversal sarcomere M-band changes 
in AMs, we developed a new confocal imaging strategy using previous-
ly described GFP-tagged titin-knockin mice (38). Additional details 
are provided in the Supplemental Methods.
Immunofluorescence microscopy. Cells on coverslips were fixed with 
4% PFA and permeabilized with 0.2% Triton. Cells were processed 
for immunofluorescence microscopy as described previously (9, 29). 
Confocal fluorescence images were obtained with a Zeiss LSM 710 
NLO and super-resolution images with a Leica TCS STED laser-scan-
ning microscope. Fluorophores were excited at 458 nm, 488 nm, 514 
nm, 561 nm, 580 nm, or 633 nm, and emission of dual or triple fluoro-
phore combinations detected. All primary Abs and dilutions are sum-
marized in Supplemental Table 3. RyR2-pS2814 Abs were provided by 
Xander H.T. Wehrens (Baylor College of Medicine, Houston, Texas, 
USA). Images were processed using ImageJ/Fiji (NIH) as described 
previously (9, 18). RyR2, RyR2-pS2808, RyR2-pS2814, Cav1.2, and 
Cav3 signals in AMs and NND relations were analyzed with macros 
using Fiji. Further details are provided in the Supplemental Methods.
PCR. Refer to the Supplemental Methods for a modified 
genotyping protocol involving the RyR2-S2808A+/+-knockin mice 
described previously (29).
Western blots. Protein extracts from cardiac tissue lysates were pre-
pared as described previously (9, 40). The primary Abs used are listed in 
Supplemental Table 3 and the complete gels in Supplemental Figure 10.
TAC and histology. TAC was used to induce LA hypertrophy in 
WT mice according to previously described protocols (52). Additional 
details are provided in the Supplemental Methods.
Echocardiography. Atrial dimensions were measured using a left 
parasternal long-axis view at the level of the aortic valve tip during simul-
taneous surface electrocardiogram recording (Vevo 2100; VisualSonics).
Statistics. Statistical analyses were performed with Microsoft 
Excel, GraphPad Prism (version 5.01), and SigmaPlot (Systat Soft-
ware). Differences were analyzed by unpaired 2-tailed Student’s t test, 
Mann-Whitney U test, or ANOVA. Data are presented as the mean 
± SEM unless otherwise indicated. P values < 0.05 were accepted to 
indicate statistical significance.
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